Brian Cameron, MD
Neurological Surgery · Richmond, VANPI 1235346354
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 4 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Medtronic accounts for 89.7% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2019 at $120 and has fallen 85.0% since, to $18 in 2025. That places this record below the midpoint for neurological surgery clinicians in VA, where the typical reported total is $2,608.
Across 4 payments — averaging $43.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$156
- VB Spine LLC$18
Across 87 payments — averaging $7449.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$257K
- AbbVie$254K
- Integra Lifesciences Corporation$68K
- Mitsubishi Tanabe Pharma Development America, Inc.$40K
- Vertex$24K
- Biogen$5K
- plus $51 from 1 others
What the payments were for
- Food & beverage$174100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 3 | $156 |
| VB Spine LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RESTORE$115
How this compares
$174 in reported general payments places this provider in the 15th percentile of 156 neurological surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 69 | $561 |
| Methocarbamol | 46 | $488 |
| Pregabalin | 25 | $483 |
| Diclofenac Sodium | 18 | $225 |
| Methylprednisolone | 25 | $177 |
| Amitriptyline Hcl | 16 | $123 |
| Nortriptyline Hcl | 12 | $93 |
| Oxycodone Hcl | 25 | $86 |
| Tizanidine Hcl | 12 | $59 |
| Tramadol Hcl | 20 | $36 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Richmond
- James MooneyRichmond$93K
- Dennis RivetRichmond$45K
- Robert GrahamRichmond$37K
- Kathryn HollowayRichmond$20K
- John Reavey-CantwellRichmond$17K
- Kanwalcharan SahniRichmond$11K
- Ketan VermaRichmond$5K
- Justin SmithCharlottesville$2.3M
- David VincentVirginia Beach$959K
- Mudit SharmaManassas$714K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.